Incyte, a renowned biopharmaceutical company, has acquired Escient Pharmaceuticals, a pioneer in developing small molecule therapeutics for immune disorders....

The international gene therapy trial for Duchenne Muscular DystrophyDuchenne Muscular Dystrophy (DMD) using GNT0004 has unveiled promising findings at...

Medpace Holdings reported a significant financial performance for the first quarter of 2024. Revenue soared by 17.7% to $511...

The U.S. Food and Drug Administration (FDA) has granted approval for ANKTIVA, a novel immunotherapy, in combination with Bacillus...

Azitra, a biopharmaceutical company specializing in dermatology therapies, announced promising preclinical data demonstrating the potential of its platform for...

Neurogene’s NGN-401 gene therapy for Rett syndrome has exhibited promising safety results in initial clinical trials. After several months...

Lantern Pharma has received regulatory approval to expand its Phase 2 clinical trial (HarmonicTM) to evaluate the efficacy of...

The European Commission has approved EMBLAVEO® (aztreonam-avibactam) as a treatment for severe infections caused by Gram-negative bacteria. This includes...

Two comprehensive studies have demonstrated the effectiveness of algorithm-driven alerts in optimizing antibiotic selection for hospitalized patients with pneumonia...

In a conversation with Ramita Tandon, Walgreens’ Chief Clinical Trials Officer, we explore the company’s cutting-edge strategies to maximize...